Shares of both Geron (GERN) and Madrigal Pharmaceuticals (MDGL) are soaring after receiving positive news from the Food and Drug Administration. For Geron, an FDA advisory panel backed its blood disorder treatment. For Madrigal, the FDA approved its treatment for a liver disease known as nonalcoholic steatohepatitis, or NASH. Yahoo Finance’s Josh Lipton and Julie Hyman discuss the stocks’ reaction in the video above. For more expert insight and the latest market action, click here to watch this… Source link
Read More »Catalyst Pharmaceuticals Set to Join S&P SmallCap 600
NEW YORK, Sept. 12, 2022 /PRNewswire/ — Catalyst Pharmaceuticals Inc. (NASD: CPRX) will replace Mantech International Corp. (NASD: MANT) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, September 15. The Carlyle Group Inc. (NASD: CG) is acquiring ManTech International in a transaction expected to be completed soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date
Read More »J&J to spin off consumer products and focus on pharmaceuticals
By Michael Erman and Manas Mishra (Reuters) – Johnson & Johnson plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest shake-up in the U.S. company’s 135-year history. The move by the world’s largest health products company follows similar announcements by conglomerates Toshiba https://www.reuters.com/technology/toshiba-set-announce-split-into-three-firms-shareholder-reaction-focus-2021-11-12 General… Source link
Read More »